1. Main page
  2. Pharmaceuticals
  3. Tenax Therapeutics

Tenax Therapeutics

4 Decision Makers · 4 Verified Contacts & Email Format

tenaxthera.com
📍 Chapel Hill, North Carolina, United StatesPharmaceuticals🗓 Est. 1967👥 11–50 employees

About Tenax Therapeutics

Tenax Therapeutics focuses on identifying and developing treatments that address cardiovascular and pulmonary diseases.

Email Format

{first_name}.{last_name}@tenaxthera.com — 100.0%

sarah.smith@tenaxthera.com

Leadership & Decision Makers

Contact details of 4 Tenax Therapeutics decision makers

Stuart Rich

CMO

  • Work email

    s*********h@tenaxthera.com

Michael B. Jebsen

CFO

Eliot Lurier

Interim Chief Financial Officer

Chris Giordano

President & CEO

General Emails

General company emails, e.g. customer support lines

    info@tenaxthera.com

    General Inquiries

    administrator@tenaxthera.com

    Unclassified inbox

Verify Tenax Therapeutics Emails

Similar Companies like Tenax Therapeutics

Rakuten Medical

rakuten-med.com
Pharmaceuticals · San Diego, CA · Est. 2010 · 101–250 employees

HQ: San Diego, CA

Eagle Pharmaceuticals

eagleus.com
Biotechnology · Woodcliff Lake, New Jersey, United States · Est. 2007 · 101–250 employees

HQ: Woodcliff Lake, New Jersey, United States

Loxo Oncology

loxooncology.com
Pharmaceuticals · New York, NY · Est. 2013 · 501–1000 employees

HQ: New York, NY

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology · Temple City, California, United States · Est. 2011 · 1001–5000 employees

HQ: Temple City, California, United States

Explore similar firms in the Pharmaceuticals sector

Company Info

Last updated: 13/07/2025

tenaxthera.com

9198552133

Chapel Hill, North Carolina, United States

Specialization: Biopharmaceutical, Therapeutics,
Legal Name: Tenax Therapeutics, Inc.
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Founded Date: 1967
Company Type: For Profit
Stock Symbol: NASDAQ:TENX
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: 9198552133
Last Investment Activity: Feb 20, 2024
Investments Activity: Feb 20, 2024 Feb 8, 2024 Feb 8, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.